Literature DB >> 3123257

Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron.

M Feelisch1, E Noack.   

Abstract

The aim of the present study was to exclude a potential role of hemoglobin in the formation of nitric oxide (NO) from several nitrovasodilators. NO was measured with a chemiluminescence technique after purging with argon from the aqueous solution. Nitric oxide generation occurred in the absence of hemoglobin or non-heme iron. Sodium nitroprusside and SIN-1 released NO spontaneously. Nitroglycerin produced NO only in the presence of those thiols which are effective co-stimulators of guanylate cyclase. All other thiols degraded nitroglycerin only into nitrite ions without formation of NO. Our results support the role of nitric oxide as terminal activator of guanylate cyclase stimulation by nitrovasodilators.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3123257     DOI: 10.1016/0014-2999(87)90090-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  35 in total

1.  Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries.

Authors:  M E Murphy
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.

Authors:  R J Gryglewski; A Zembowicz; D Salvemini; G W Taylor; J R Vane
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  Pre- and postjunctional protective effect of neocuproine on the nitrergic neurotransmitter in the mouse gastric fundus.

Authors:  J G De Man ; T G Moreels; B Y De Winter ; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Elevated guanosine 3':5'-cyclic monophosphate mediates the depression of nitrovasodilator reactivity in endothelium-intact blood vessels.

Authors:  W F Jackson; R Busse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

5.  Use of a hemoglobin-trapping approach in the determination of nitric oxide in in vitro and in vivo systems.

Authors:  A Balcioglu; C J Watkins; T J Maher
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

6.  Investigation of the interaction between nitric oxide and vasoactive intestinal polypeptide in the guinea-pig gastric fundus.

Authors:  J M Dick; L A Van Geldre; J P Timmermans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

Review 7.  Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.

Authors:  L J Ignarro
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

8.  N-acetylcysteine fails to attenuate haemodynamic tolerance to glyceryl trinitrate in healthy volunteers.

Authors:  J C Hogan; M J Lewis; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

9.  Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation.

Authors:  T W Vickroy; W L Malphurs
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

10.  Activity of nitric oxide-generating compounds against encephalomyocarditis virus.

Authors:  E Guillemard; M Geniteau-Legendre; R Kergot; G Lemaire; J F Petit; C Labarre; A M Quero
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.